HCV Vaccine Boosts Response to Standard Treatment
Friday, April 23rd, 2010Tarmogen Vaccine, GI-5005, increased virologicl response in phase II trial.
http://www.docguide.com/news/content.nsf/news/852576140048867C8525770D0067832B
HCV Vaccine Boosts Response to Standard TreatmentFriday, April 23rd, 2010Tarmogen Vaccine, GI-5005, increased virologicl response in phase II trial. http://www.docguide.com/news/content.nsf/news/852576140048867C8525770D0067832B Financial Help for HCV TreatmentWednesday, January 6th, 2010We have been receiving several inquiries on how to get financial assistance for HCV treatment both in the U.S. and abroad. We are not able to provide any money from the Greenview Hepatitis C Fund for this purpose, but are interested in steering people to available resources. Most major pharmaceutical companies offer “Patient Assistance Programs” to provide free or low cost medications to those unable to pay. Here are some I found: Merck/Schering-Plough http://www.rxassist.org/pap-info/company_detail.cfm?CmpId=124 General search http://www.pparx.org/prescription_assistance_programs/list_of_participating_programs Roche http://www.gene.com/gene/products/access/roche/ Pegasys http://www.patientassistance.com/B5790-pegasys.html BioPlus Specialty Pharmacy Services, 376 Northlake Blvd., Altamonte Springs Fl. 32701, U.S. (888-292-0744, Fax: 800-269-5493). Contact me at Debbie@hepcfund.org for the PDF version of their brochure. If you have been able to get financial help for HCV treatment and you do not see your program listed here, please notify us either in a comment on this blog or email me at Debbie@hepcfund.org. |
|
About Us | Research | Cookbook | Memorial | Events | Blog | Support Us | Privacy Greenview Foundation © 2009 |